Show simple item record

dc.contributor.authorScotland, Graham Stewart
dc.date.accessioned2015-12-02T12:31:01Z
dc.date.available2015-12-02T12:31:01Z
dc.date.issued2015-09
dc.identifier.citationScotland , G S 2015 ' Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? HERU Policy Brief ' University of Aberdeen , Aberdeen , pp. 1-2 .en
dc.identifier.otherPURE: 59572637
dc.identifier.otherPURE UUID: c3398e12-3f01-45e2-b2d5-9883b3c5af19
dc.identifier.urihttp://hdl.handle.net/2164/5273
dc.identifier.urihttps://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_Sept_2015.pdfen
dc.descriptionThe work carried out for this project was commissioned by NICE and funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE, the NIHR HTA Programme, NIHR, NHS or Department of Health. Investigators and researchers on this project were Pawana Sharma, Graham Scotland, Moira Cruickshank, Emma Tassie, Cynthia Fraser, Christopher Burton, Bernard Croal, Craig R Ramsay, and Miriam Brazzelli.en
dc.format.extent2en
dc.language.isoeng
dc.publisherUniversity of Aberdeen
dc.relation.ispartofen
dc.subjectWarfarinen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleIs self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? : HERU Policy Briefen
dc.typeWorking or discussion paperen
dc.contributor.institutionUniversity of Aberdeen, Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.description.versionPublisher PDFen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record